Marksans Pharma Gets USFDA Final Approval for Anti-Diarrheal Medication

Overview

Marksans Pharma's wholly-owned subsidiary, Marksans Pharma Inc., has received final approval from the US Food and Drug Administration (USFDA) for its generic Loperamide Hydrochloride Tablets USP, 2 mg. This anti-diarrheal medication is bioequivalent to Imodium A-D Tablets and marks a significant step for the company's market presence in the United States.